Abstract
The relationship between the GOT/GPT ratio in nonviral liver disorders and underlying physical condition and life-style were evaluated. The subjects were 12,808 male railway company workers who underwent an annual health checkup. Nonviral liver disorders were defined as elevated transaminases (GOT > 76 IU/liter or GPT > 86 IU/liter, while negative for hepatitis B and C markers (282 cases). Controls were 9783 males with normal findings for GOT, GPT, and γ-GTP. By logistic regression analysis, GOT-dominant liver disorders were significantly related to alcohol consumption, hypertriglyceridemia, and diabetes mellitus. They were still significant on multivariate analysis. GPT-dominant liver disorders were significantly related to obesity, less exercise, hypercholesterolemia, and hypertriglyceridemia. Obesity and hypercholesterolemia were significant on multivariate analysis. In conclusion, the relationship between hypertriglyceridemia or diabetes mellitus and GOT-dominant disorders, which was not explained empirically, could indicate another pathogenesis for nonviral liver disorders, such as underlying insulin resistance.
Similar content being viewed by others
REFERENCES
Sherlock S, Dooley J: Chronic hepatitis. In Diseases of the Liver and Biliary System. London, Blackwell Science, pp 303–335
Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH: Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 12(4 Pt 1):671–675, 1990
Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI: Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97:2859–2865, 1996
Okubo A, Kameyama S: The transaminase (aminotransferase). In The Approach of Determination of Serum Enzyme to Abnormal-Disease State. M Kitamura (ed). Tokyo, Igakushoin, 1985, pp 1–28, (in Japanese)
Colon JA, Kaplan MM: The SGOT/SGPT ratio: An indicator of alcoholic liver disease. Dig Dis Sci 24:835–838, 1979
Chayama K, Saitoh S, Arase Y, Ikeda K, Matsumoto T, Sakai Y, Kobayashi M, Unakami M, Morinaga T, Kumada H: Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C. Hepatology 13(6):1040–1043, 1991
Kondo Y, Hibino K: The viral hepatitis. Nipponrinsho, Suppl. for liver diseases. Tokyo, Nipponrinsho-sha, 1998, pp 30–32 (in Japanese)
Furuta S: The clinic of the hepatitis type C. J Jpn Soc Intern Med 83:1430–1438, 1993
Yano M, Yatsuhashi H, Inoue O, Inokuchi K, Koga M: Epidemiology and long term prognosis of hepatitis C virus infection in Japan. Gut 34(suppl 2): 13–16, 1993
SPSS: Base 9.0J for Windows User's Guide. Chicago, SPSS Inc, 1999
SPSS: Advanced Models 9.0. Chicago, SPSS Inc, 1999
SPSS: Regression Models 9.0. Chicago, SPSS Inc, 1999
Saito Y, Yagyu K, Hattori Y, Ohno K, Okamoto N, Takahashi A, Ohtsuka S, Ohtsuka T, Maeda K, Okamoto K, Kato T: A study on fatty in health examination participants. Jpn J Hyg 44:953–961, 1989
Braillon A, Capron JP, Herve MA, Degott C, Quenum C: Liver in obesity. Gut 26(2):133–139, 1985
Ishii M, Toyota T: Electron microscopic study of lipoproteinlike particles and lipid droplets in human fatty liver. J Clin Electron Microsc 82:193–202, 1985
Stone BG, Van Thiel DH: Diabetes Mellitus and Liver. In Seminars in Liver Disease. DH Van Thiel (ed). New York, Thieme, 1985, pp 8–28
Balasse EO, Bier DM; Havel RJ: Early effects of anti-insulin serum on hepatic metabolism of plasma free fatty acids in dogs. Diabetes 21(5):280–288, 1972
Heimberg M, Weinstein I, Kohout M: The effects of glucagon, dibutyril cyclic adenosine 3´,5´-monophoshate, and concentration of free fatty acid on hepatic lipid metabolism. J Biol Chem 244(19):5131–5139, 1969
Abram JJ, Ginsberg H, Grundy SM Metabolism of cholesterol and plasma triglycerides in nonketotic diabetes mellitus. Diabetes 31(10):903–910, 1982
Ishi H: Fatty liver. In The Internal Medicine. T Sugimoto, M Omata (eds). Tokyo, Asakura Shoten, 1999, pp 1034–1036 (in Japanese)
Sherlock S, Dooley J: Nutritional and metabolic liver diseases. In Diseases of the Liver and Biliary System. London, Blackwell Science, pp 427–454
Alpers DH, Sabesin SM: Fatty liver: Biochemical and clincal aspects. In Disease of Liver. L Schiff, ER Schiff (eds). Philadelphia, JB Lippincott, 1987, pp 949–978
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mukai, M., Ozasa, K., Hayashi, K. et al. Various S-GOT/S-GPT Ratios in Nonviral Liver Disorders and Related Physical Conditions and Life-Style. Dig Dis Sci 47, 549–555 (2002). https://doi.org/10.1023/A:1017959801493
Issue Date:
DOI: https://doi.org/10.1023/A:1017959801493